Lehi, Utah, referred to as 'Silicon Slopes,' was chosen because it is centrally located amid Utah's universities and has become a hub for the state's start-up and tech community.
Civica Rx, the health system-led supplier of generic medications, has opened its new headquarters in Lehi, Utah.
The company was created in September 2018 by 12 founding health systems across the nation to address spiraling costs and chronic shortages of essential generic medications. It has since grown to include an additional 12 health systems, representing about 750 hospitals nationwide.
Lehi, referred to as "Silicon Slopes," was chosen because it is centrally located amid Utah's universities and has become a hub for the state's start-up and tech community, Civica Rx said in a media release.
Civica Rx has identified –- but has yet to publicly name -- 14 hospital-administered generic drugs as its initial focus, seeking to stabilize the supply of essential medications, many of which face chronic shortages. The company expects to release its first products this year.
"Together we celebrate the reason why Civica Rx exists, in purpose and in brick and mortar, and that is to do what is in the best interest of patients by stabilizing the supply of generic medications," said Martin VanTrieste, Civica Rx CEO.
"Drug shortages strain hospital staff, lead to delayed surgeries and sub-optimal treatments for patients, and can lead to unpredictable price increases that result in budgetary instability in hospitals," he said.
VanTrieste was joined at a ribbon cutting ceremony on Thursday by a host of dignitaries, including Utah Gov. Gary Herbert, Intermountain Healthcare CEO Marc Harrison, MD, and Civica Rx Chairman Dan Liljenquist, who's credited as the "brainchild" of the Civica Rx initiative.
The Lehi office will employ 40 people and expansion opportunities in Lehi are expected to bring the office to four or five times that size within three to five years, Civica Rx said.
“Together we celebrate the reason why Civica Rx exists, in purpose and in brick and mortar, and that is to do what is in the best interest of patients by stabilizing the supply of generic medications.”
Civica Rx CEO Martin VanTrieste
John Commins is the news editor for HealthLeaders.
Photo credit: Aleksandra Gigowska / Shutterstock
KEY TAKEAWAYS
The company was created in September 2018 by 12 founding health systems across the nation to address spiraling costs and chronic shortages of generic medications.
It has since grown to include an additional 12 health systems, representing about 750 hospitals nationwide.
Civica Rx has identified –- but has yet to publicly name -- 14 hospital-administered generic drugs as its initial focus.
The company expects to release its first products this year.